E R Dubberke

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Acute meningoencephalitis caused by adenovirus serotype 26
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Neurovirol 12:235-40. 2006
  2. pmc Multicenter study of Clostridium difficile infection rates from 2000 to 2006
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, Box 8051, 660 South Euclid, St Louis, MO 63110, USA
    Infect Control Hosp Epidemiol 31:1030-7. 2010
  3. pmc Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes
    Erik R Dubberke
    Washington University School of Medicine, St Louis, Missouri, USA
    Infect Control Hosp Epidemiol 31:262-8. 2010
  4. pmc Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
    Clin Transplant 24:192-8. 2010
  5. doi request reprint Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Infect Control Hosp Epidemiol 30:518-25. 2009
  6. pmc Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
    Erik R Dubberke
    Washington University School of Medicine, St Louis, Missouri, USA
    Infect Control Hosp Epidemiol 30:332-7. 2009
  7. pmc The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Clin Infect Dis 53:20-5. 2011
  8. doi request reprint Review of current literature on the economic burden of Clostridium difficile infection
    Erik R Dubberke
    Infectious Diseases Division, Department of Medicine, Washington University in St Louis, School of Medicine, St Louis, Missouri 63110, USA
    Infect Control Hosp Epidemiol 30:57-66. 2009
  9. doi request reprint Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients
    Erik R Dubberke
    Washington University School of Medicine, Saint Louis, Missouri, USA
    Clin Infect Dis 46:497-504. 2008
  10. pmc ICD-9 codes and surveillance for Clostridium difficile-associated disease
    Erik R Dubberke
    Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA
    Emerg Infect Dis 12:1576-9. 2006

Detail Information

Publications31

  1. ncbi request reprint Acute meningoencephalitis caused by adenovirus serotype 26
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Neurovirol 12:235-40. 2006
    ..In this article the authors report a case of adenoviral meningoencephalitis caused by serotype 26 and its identification, not described previously, in cerebrospinal fluid (CSF) by PCR and brain tissue by immunohistochemical staining...
  2. pmc Multicenter study of Clostridium difficile infection rates from 2000 to 2006
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, Box 8051, 660 South Euclid, St Louis, MO 63110, USA
    Infect Control Hosp Epidemiol 31:1030-7. 2010
    ....
  3. pmc Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes
    Erik R Dubberke
    Washington University School of Medicine, St Louis, Missouri, USA
    Infect Control Hosp Epidemiol 31:262-8. 2010
    ..difficile toxin assay results...
  4. pmc Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
    Clin Transplant 24:192-8. 2010
    ..6, 95% CI 1.1-6.2). CDAD is a significant cause of morbidity and mortality in allogeneic HSCT patients, but modifiable risk factors exist. Further study is needed to determine the best methods of decreasing patients' risk of CDAD...
  5. doi request reprint Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Infect Control Hosp Epidemiol 30:518-25. 2009
    ..To evaluate the impact of cases of community-onset, healthcare facility (HCF)-associated Clostridium difficile infection (CDI) on the incidence and outbreak detection of CDI...
  6. pmc Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
    Erik R Dubberke
    Washington University School of Medicine, St Louis, Missouri, USA
    Infect Control Hosp Epidemiol 30:332-7. 2009
    ....
  7. pmc The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Clin Infect Dis 53:20-5. 2011
    ..Whether ICD-9-CM code rank order affects CDI prevalence estimates is important because the National Hospital Discharge Survey (NHDS) and the Nationwide Inpatient Sample (NIS) have varying limits on the number of ICD-9-CM codes collected...
  8. doi request reprint Review of current literature on the economic burden of Clostridium difficile infection
    Erik R Dubberke
    Infectious Diseases Division, Department of Medicine, Washington University in St Louis, School of Medicine, St Louis, Missouri 63110, USA
    Infect Control Hosp Epidemiol 30:57-66. 2009
    ..To more completely assess its economic burden, we performed a review of available literature that reported costs associated with the infection...
  9. doi request reprint Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients
    Erik R Dubberke
    Washington University School of Medicine, Saint Louis, Missouri, USA
    Clin Infect Dis 46:497-504. 2008
    ..There are few data on the short-term and long-term attributable costs of CDAD. The objective of this study was to determine the acute and 180-day attributable inpatient costs of CDAD...
  10. pmc ICD-9 codes and surveillance for Clostridium difficile-associated disease
    Erik R Dubberke
    Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA
    Emerg Infect Dis 12:1576-9. 2006
    ..The correlation between toxin assay results and ICD-9 codes was good (K = 0.72, p<0.01). The sensitivity of the ICD-9 codes was 78% and the specificity was 99.7%...
  11. ncbi request reprint Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system
    Erik R Dubberke
    Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO 63110, USA
    Infect Control Hosp Epidemiol 28:208-11. 2007
    ..Patients with severe CDAD had significantly shorter median survival times and more adverse outcomes than patients with mild or moderate CDAD...
  12. ncbi request reprint Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease
    Erik R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Arch Intern Med 167:1092-7. 2007
    ..The purpose of this study was to evaluate CDAD pressure, a modified form of colonization pressure based on symptomatic CDAD cases, as a risk factor for CDAD...
  13. ncbi request reprint Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities
    Erik R Dubberke
    Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Infect Control 35:315-8. 2007
    ..difficile environmental contamination at various health care facilities in a metropolitan area and determine if the North American pulsed field gel electrophoresis type 1 (NAP1) strain was present...
  14. doi request reprint Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors
    Erik R Dubberke
    Washington University School of Medicine, St Louis, Missouri, USA
    Clin Infect Dis 45:1543-9. 2007
    ..The purpose of this study was to determine risk factors for endemic CDAD, including CDAD pressure, a modified version of colonization pressure...
  15. ncbi request reprint Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?
    E R Dubberke
    Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO 63110, USA
    Bone Marrow Transplant 38:813-9. 2006
    ..Our analysis suggests that in patients with hematological malignancies or HSCT, VRE may not have the behavior of a virulent pathogen. VRE BSI may simply be a marker of these patients' already existing critical medical condition...
  16. pmc Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients
    Erik R Dubberke
    Washington University School of Medicine, St Louis, Missouri, USA
    Emerg Infect Dis 14:1031-8. 2008
    ..Even in a nonoutbreak setting, CDAD had a statistically significant negative impact on patient illness and death, and the impact of CDAD persisted beyond hospital discharge...
  17. pmc Clostridium difficile infection in the intensive care unit
    David J Riddle
    Division of Infectious Diseases, Departments of Medicine and Pediatrics, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8051, St Louis, MO 63110 1093, USA
    Infect Dis Clin North Am 23:727-43. 2009
    ..This article seeks to provide a broad understanding of CDI in the intensive care unit, with special emphasis on risk factor identification, treatment options, and disease prevention...
  18. ncbi request reprint Incidence of Clostridium difficile infection in inflammatory bowel disease
    Joseph F Rodemann
    Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Clin Gastroenterol Hepatol 5:339-44. 2007
    ..We sought to determine whether CDAD incidence has increased specifically in hospitalized patients with IBD. We also explored possible differences in the risk for and time to presentation of CDAD between IBD and non-IBD patients...
  19. pmc Identification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDI
    Marina Litvin
    Department of Medicine, Washington University School of Medicine, Barnes Jewish Hospital, St Louis, Missouri 63110, USA
    Infect Control Hosp Epidemiol 30:1166-71. 2009
    ..difficile on perceived CDI burden, positive predictive value, and false-positive results...
  20. doi request reprint Clostridium difficile infection in solid organ transplant recipients
    David J Riddle
    Division of Infectious Diseases, Department of Medicine, Washington University in St Louis, St Louis, Missouri 63110, USA
    Curr Opin Organ Transplant 13:592-600. 2008
    ..To provide a general understanding of Clostridium difficile infection with a focus on recent publications that evaluate the disease in solid organ transplant recipients...
  21. doi request reprint Case-control study of clinical features of influenza in hospitalized patients
    Hilary M Babcock
    Washington University School of Medicine, Infectious Diseases Division, St Louis, Missouri 63110, USA
    Infect Control Hosp Epidemiol 29:921-6. 2008
    ..Few data exist on the clinical presentation of influenza in hospitalized patients, which may be distinct from the clinical presentation of influenza in ambulatory patients because of underlying medical conditions and medications...
  22. pmc Prevention of healthcare‚Äźassociated Clostridium difficile infection: what works?
    Erik R Dubberke
    Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
    Infect Control Hosp Epidemiol 31:S38-41. 2010
    ..difficile infection. Studies are needed to define the optimal prevention practices and to investigate novel prevention methods...
  23. pmc Recognition and prevention of hospital-associated enteric infections in the intensive care unit
    Linda D Bobo
    Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
    Crit Care Med 38:S324-34. 2010
    ..In addition, intensivists should be ready to implement systems changes related to notification, isolation precautions and prevention, and environmental cleaning in the ICU...
  24. doi request reprint Micafungin for the prophylaxis and treatment of Candida infections
    Joseph M Fritz
    Washington University School of Medicine, Division of Infectious Diseases, Department of Internal Medicine, 660 South Euclid Avenue, Campus Box 8051, St Louis, MO 63110, USA
    Expert Rev Anti Infect Ther 6:153-62. 2008
    ..In general, micafungin is well tolerated and has favorable safety and drug-interaction profiles...
  25. pmc Risk factors associated with methicillin-resistant Staphylococcus aureus colonization on hospital admission among oncology patients
    Adam M Schaefer
    Barnes Jewish Hospital, St Louis, MO, USA
    Am J Infect Control 37:603-5. 2009
    ..Risk factors for any S aureus and MRSA colonization on admission in oncology patients are consistent with previous studies in general populations. In addition, recent chemotherapy as a risk factor is a unique finding in this population...
  26. doi request reprint Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever
    Heather M Arnold
    Department of Pharmacy, Barnes Jewish Hospital, St Louis, Missouri 63110, USA
    Pharmacotherapy 29:914-23. 2009
    ....
  27. pmc The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge
    E R Dubberke
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Zoonoses Public Health 58:4-20. 2011
    ..difficile infection in humans, and to stress that collaboration between human and veterinary researchers is needed to control this pathogen...
  28. pmc Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients
    Bryan T Alexander
    Department of Pharmacy, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Pharmacotherapy 30:554-61. 2010
    ..To describe the characteristics and clinical outcomes of hematopoietic stem cell transplant (HSCT) recipients who received adjunctive cytomegalovirus intravenous immune globulin (CMV-IVIG) for probable or proven CMV disease...
  29. pmc Clostridium difficile infection: a re-emerging threat
    Hitoshi Honda
    Infectious Diseases Division, Washington University of School of Medicine, USA
    Mo Med 106:287-91. 2009
    ..Effective prevention measures for C. difficile infection include contact precautions and antimicrobial stewardship. Awareness of C. difficile infection is critical to provide appropriate clinical care...
  30. ncbi request reprint A woman from Honduras with a painful forearm and fever
    Erik R Dubberke
    Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Trop Med Hyg 78:697-8. 2008
  31. doi request reprint Clostridium difficile-associated disease treatment response depends on definition of cure
    Steven J Lawrence
    Clin Infect Dis 45:1648; author reply 1649-51. 2007